GGrantIndex
← Leaderboards

Robert Tarran

University Of North Carolina Chapel Hill

Google Scholar ↗PubMed ↗ORCID ↗
$14,684,501
Attributed
$16,139,173
Total exposure
12
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6.2M · FY2005–25
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$37,117,568 · 13

By mechanism

P50$28,014,720 · 5
R01$5,002,145 · 3
R42$2,288,078 · 1
R33$542,500 · 1
R61$542,500 · 1
R21$427,625 · 1

Top collaborators

Most similar at University Of North Carolina Chapel Hill

Same institution · by research overlap

Others in their field

Top investigators on “Lung”

Research focus

LungCystic FibrosisInfectionInflammationSignal TransductionMucous Body SubstanceProteinsCystic Fibrosis Transmembrane Conductance RegulatorChronic Obstructive Airway DiseaseAffectIn VivoEpithelialTobacco ExposureMucinsSodium ChlorideWaterBasePathogenExtracellularTobaccoCellsBreathingResponseSmoker

Grant awards (49)

Optimizing ELD607 for Delivery by Inhalation$542,500
R33 · FY2025 · HL · contact PI
Optimizing ELD607 for Delivery by Inhalation$542,500
R61 · FY2024 · HL · contact PI
ELD607 Orai1 Antagonist Increases Bacterial Clearance from the Lung$988,238
R42 · FY2022 · AI · contact PI
Novel Peptide Fusion Inhibitors for the Treatment of COVID-19$300,000
R41 · FY2022 · AI · contact PI
ELD607 Orai1 Antagonist Increases Bacterial Clearance from the Lung$999,840
R42 · FY2021 · AI · contact PI
The effect of Inhaled Nicotine on Pulmonary Surfaces$557,231
R01 · FY2021 · HL · contact PI
Do E-Cigarette Users Airways Have an Altered Lipid Content?$233,250
R21 · FY2021 · HL · contact PI
The effect of Inhaled Nicotine on Pulmonary Surfaces$465,175
R01 · FY2020 · HL · contact PI
The effect of Inhaled Nicotine on Pulmonary Surfaces$456,000
R01 · FY2020 · HL · contact PI
ELD607 Orai1 Antagonist Increases Bacterial Clearance from the Lung$300,000
R42 · FY2020 · AI · contact PI
Do E-Cigarette Users Airways Have an Altered Lipid Content?$194,375
R21 · FY2020 · HL · contact PI
The effect of Inhaled Nicotine on Pulmonary Surfaces$62,939
R01 · FY2020 · HL · contact PI
The effect of Inhaled Nicotine on Pulmonary Surfaces$456,000
R01 · FY2019 · HL · contact PI
The effect of Inhaled Nicotine on Pulmonary Surfaces$456,000
R01 · FY2018 · HL · contact PI
The Impact of Tobacco Exposure on the Lungs Innate Defense System$3,999,997
P50 · FY2017 · HL · contact PI
Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd$611,626
P50 · FY2017 · HL · contact PI
The effect of Inhaled Nicotine on Pulmonary Surfaces$456,000
R01 · FY2017 · HL · contact PI
Developmental/Pilot Research Component$192,554
P50 · FY2017 · HL · contact PI
Core A: Administration and Bioanalysis Core$177,449
P50 · FY2017 · HL · contact PI
The Impact of Tobacco Exposure on the Lungs Innate Defense System$3,999,997
P50 · FY2016 · HL · contact PI
Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd$609,861
P50 · FY2016 · HL · contact PI
Developmental/Pilot Research Component$192,000
P50 · FY2016 · HL · contact PI
Core A: Administration and Bioanalysis Core$176,937
P50 · FY2016 · HL · contact PI
The Impact of Tobacco Exposure on the Lungs Innate Defense System$3,999,997
P50 · FY2015 · HL · contact PI
The Impact of Tobacco Exposure on the Lungs Innate Defense System$677,854
P50 · FY2015 · HL · contact PI
Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd$609,861
P50 · FY2015 · HL · contact PI
SPLUNC1-Derived Peptides as ENaC Antagonists$357,878
R01 · FY2015 · HL · contact PI
The Impact of Tobacco Exposure on the Lungs Innate Defense System$200,558
P50 · FY2015 · HL · contact PI
Developmental/Pilot Research Component$192,000
P50 · FY2015 · HL · contact PI
Core A: Administration and Bioanalysis Core$176,937
P50 · FY2015 · HL · contact PI
The Impact of Tobacco Exposure on the Lungs Innate Defense System$3,999,997
P50 · FY2014 · HL · contact PI
Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd$609,861
P50 · FY2014 · HL · contact PI
SPLUNC1-Derived Peptides as ENaC Antagonists$356,061
R01 · FY2014 · HL · contact PI
Developmental/Pilot Research Component$192,000
P50 · FY2014 · HL · contact PI
Core A: Administration and Bioanalysis Core$176,937
P50 · FY2014 · HL · contact PI
The Impact of Tobacco Exposure on the Lungs Innate Defense System$99,999
P50 · FY2014 · HL · contact PI
The Impact of Tobacco Exposure on the Lungs Innate Defense System$3,999,996
P50 · FY2013 · HL · contact PI
Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd$709,860
P50 · FY2013 · HL · contact PI
SPLUNC1-Derived Peptides as ENaC Antagonists$345,888
R01 · FY2013 · HL · contact PI
Core A: Administration and Bioanalysis Core$176,937
P50 · FY2013 · HL · contact PI
SPLUNC1-Derived Peptides as ENaC Antagonists$363,328
R01 · FY2012 · HL · contact PI
ASL volume and innate defense in CF and COPD Airways$497,493
P50 · FY2010 · HL · contact PI
ASL volume and innate defense in CF and COPD Airways$483,031
P50 · FY2009 · HL · contact PI
ASL volume and innate defense in CF and COPD Airways$459,774
P50 · FY2008 · HL · contact PI
ASL volume and innate defense in CF and COPD Airways$459,332
P50 · FY2007 · HL · contact PI
Ion Transport and Mucus Clearance in CF Airways$207,651
R01 · FY2007 · HL · contact PI
ASL volume and innate defense in CF and COPD Airways$331,875
P50 · FY2006 · HL · contact PI
Ion Transport and Mucus Clearance in CF Airways$213,854
R01 · FY2006 · HL · contact PI
Ion Transport and Mucus Clearance in CF Airways$248,140
R01 · FY2005 · HL